Recruiting

New scanning tools to better treat infant chest infections

Plain-English translation of NCT07381790 on ClinicalTrials.gov ↗ · Source last updated February 2026 · Translation generated July 2026 · How we translate trials

What is this trial?

This study is testing whether two modern technologies — lung ultrasound (a safe scanning method similar to pregnancy ultrasounds) and tidal breathing flow volume loops (a simple breathing test) — can help doctors better understand and treat infants with lower respiratory tract infections like bronchiolitis. The goal is to identify which babies are at higher risk for long-term lung problems and tailor their care accordingly.

Right now, doctors rely mainly on clinical judgment to decide how sick an infant is and what treatment they need, which can lead to some babies being undertreated and others being overtreated. This study exists to find objective, measurable ways to assess severity and predict which infants will have lasting lung problems after their infection.

Do you qualify?

You likely qualify if…

your child is under 2 years old and hospitalized with a lower respiratory tract infection
your child has symptoms like rapid breathing, wheezing, or difficulty breathing at admission
your child weighs at least 3 kg (about 6.6 pounds)
you or your caregiver can communicate in Norwegian or English

You likely don't qualify if…

your child has severe heart disease (certain types like complex congenital heart defects)
your child has cystic fibrosis or primary ciliary dyskinesia
your child was born very prematurely (before 32 weeks) or has chronic lung disease from prematurity
your child has a neuromuscular disease or condition that affects airway clearance
your child has a diagnosed airway abnormality (malacia), foreign body in the airway, collapsed lung, or fluid around the lungs requiring surgery

What participation looks like

Your infant will have two non-invasive tests performed during their hospital stay: a lung ultrasound scan (which uses sound waves to create images, similar to a pregnancy ultrasound) and a breathing test called a tidal breathing flow volume loop (where your baby breathes normally through a small mouthpiece to measure airflow). Researchers will also collect information about your child's symptoms, length of stay, and need for respiratory support. The study is observational, meaning no new medication or invasive procedures are being tested — just these two assessment tools.

AI-generated summary from trial data · Jul 13, 2026 · Not medical advice

Trial locations(2 sites)

Norway

Aalesund Hospital, Ålesund, Møre og Romsdal

St. Olavs Hospital HF, Trondheim, Sør-Trøndelag

View full record on ClinicalTrials.gov